90 related articles for article (PubMed ID: 2959228)
1. Effect of eight-day converting enzyme inhibition on ambulatory blood pressure recordings in normotensive volunteers.
Bidiville J; Porchet M; Bussien JP; Nussberger J; Waeber B; Brunner HR
Arch Int Pharmacodyn Ther; 1987 Jul; 288(1):109-19. PubMed ID: 2959228
[TBL] [Abstract][Full Text] [Related]
2. Effect of prolonged angiotensin converting enzyme inhibition on ambulatory blood pressure of normotensive volunteers.
Bidiville J; Bussien JP; Porchet M; Nussberger J; Waeber B; Brunner HR
Clin Exp Hypertens A; 1987; 9(2-3):583-6. PubMed ID: 3038421
[TBL] [Abstract][Full Text] [Related]
3. Experience with perindopril in normal volunteers.
Waeber B; Nussberger J; Perret L; Santoni JP; Brunner HR
Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():35-41. PubMed ID: 2549899
[TBL] [Abstract][Full Text] [Related]
4. Effects of prolonged administration of the angiotensin converting enzyme inhibitor CGS 16617 in normotensive volunteers.
Waeber G; Burnier M; Porchet M; Nussberger J; Waeber B; Brunner HR
Eur J Clin Pharmacol; 1989; 36(6):587-91. PubMed ID: 2550244
[TBL] [Abstract][Full Text] [Related]
5. Effects of single doses of the converting enzyme inhibitor cilazapril in normal volunteers.
Fasanella d'Amore T; Bussien JP; Nussberger J; Waeber B; Turini GA; Brunner HR; Kler L; Francis RJ
J Cardiovasc Pharmacol; 1987 Jan; 9(1):26-31. PubMed ID: 2434790
[TBL] [Abstract][Full Text] [Related]
6. Experience with perindopril in normal volunteers.
Waeber B; Nussberger J; Perret L; Santoni JP; Brunner HR
Clin Exp Hypertens A; 1989; 11 Suppl 2():507-19. PubMed ID: 2605800
[TBL] [Abstract][Full Text] [Related]
7. The present molecules of converting enzyme inhibitors.
Brunner HR; Nussberger J; Waeber B
J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S2-11. PubMed ID: 2580170
[TBL] [Abstract][Full Text] [Related]
8. Repeated administration of the converting enzyme inhibitor cilazapril to normal volunteers.
Nussberger J; Fasanella d'Amore T; Porchet M; Waeber B; Brunner DB; Brunner HR; Kler L; Brown AN; Francis RJ
J Cardiovasc Pharmacol; 1987 Jan; 9(1):39-44. PubMed ID: 2434792
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive, enzymatic, and hormonal activity of cilazapril, a new angiotensin-converting enzyme inhibitor in patients with mild to moderate essential hypertension.
Sánchez RA; Traballi CA; Barclay CA; Gilbert HB; Muscará M; Giannone C; Moledo LI
J Cardiovasc Pharmacol; 1988 Feb; 11(2):230-4. PubMed ID: 2452319
[TBL] [Abstract][Full Text] [Related]
10. Interdependence of food intake and angiotensin converting enzyme inhibition on kidney function.
Corman B; Michel JB
J Hypertens Suppl; 1988 Dec; 6(3):S65-8. PubMed ID: 3225691
[TBL] [Abstract][Full Text] [Related]
11. Reversal of the suppressed kidney renin level in the hypertensive transgenic rat TGR(mRen-2)27 by angiotensin converting enzyme inhibition.
Tokita Y; Franco-Saenz R; Mulrow PJ
Am J Hypertens; 1995 Oct; 8(10 Pt 1):1031-9. PubMed ID: 8845072
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the pharmacokinetics and pharmacodynamics of perindopril, cilazapril and enalapril.
Louis WJ; Conway EL; Krum H; Workman B; Drummer OH; Lam W; Phillips P; Howes LG; Jackson B
Clin Exp Pharmacol Physiol Suppl; 1992; 19():55-60. PubMed ID: 1327596
[TBL] [Abstract][Full Text] [Related]
13. Effects of moderate salt restriction alone and in combination with cilazapril on office and ambulatory blood pressure.
Uusitupa M; Korhonen M; Litmanen H; Niskanen L; Väisänen S; Rauramaa R
J Hum Hypertens; 1996 May; 10(5):319-26. PubMed ID: 8817406
[TBL] [Abstract][Full Text] [Related]
14. The 24 h blood pressure responses of hypertensives to a once-a-day cilazapril regimen.
Fernandez PG; Bolli P; Lee C
Can J Cardiol; 1990 Mar; 6(2):53-8. PubMed ID: 2138051
[TBL] [Abstract][Full Text] [Related]
15. Effects of ACE inhibition with cilazapril on splanchnic and systemic haemodynamics in man.
Gasic S; Heinz G; Kleinbloesem C; Korn A
Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):225S-234S. PubMed ID: 2548552
[TBL] [Abstract][Full Text] [Related]
16. Correlation between plasma concentration of cilazapril and haemodynamic and hormonal effects in healthy man.
Burnier M; Mooser V; Nussberger J; Waeber B; Brunner HR
Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):189S-197S. PubMed ID: 2527532
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin converting enzyme inhibition, pulse wave velocity and ambulatory blood pressure measurements in essential hypertension.
Santoni JP; Asmar R; Safar ME
Clin Exp Hypertens A; 1989; 11 Suppl 2():535-44. PubMed ID: 2691127
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporin-induced hypertension in marmosets: a new model of hypertension sensitive to angiotensin-converting enzyme inhibition.
Clozel JP; Fischli W
J Cardiovasc Pharmacol; 1989 Jul; 14(1):77-81. PubMed ID: 2475720
[TBL] [Abstract][Full Text] [Related]
19. Persistent effects on blood pressure and renal function of perindopril alone or combined with losartan in Lyon hypertensive rats.
Naelten G; Liu KL; Chapuis B; Lo M
Am J Hypertens; 2005 May; 18(5 Pt 1):699-706. PubMed ID: 15882554
[TBL] [Abstract][Full Text] [Related]
20. Effect on blood pressure and the renin-angiotensin system of repeated doses of the converting enzyme inhibitor CGS 14824A.
Waeber G; Fasanella d'Amore T; Nussberger J; Waeber B; Brunner HR
Eur J Clin Pharmacol; 1987; 31(6):643-6. PubMed ID: 3030765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
